Cardium Therapeutics, Inc.: INNERCOOL Therapies to Present Next-Generation Patient Temperature Modulation Systems at New York Neurological Symposium

Published: May 16, 2007

SAN DIEGO--(BUSINESS WIRE)--Cardium Therapeutics (OTCBB:CDTP) and its operating unit InnerCool Therapies today announced that InnerCool’s two next-generation medical device systems designed to provide comprehensive solutions to patient temperature modulation will be presented at the upcoming Symposium on Neurological Emergencies & Neurocritical Care being offered by the Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital – The University Hospital of Columbia and Cornell. InnerCool’s new systems will be presented in a special session devoted to therapeutic hypothermia to be held the afternoon of May 25th, 2007, at the New York Academy of Medicine in New York City.

Back to news